Loading clinical trials...
Loading clinical trials...
A Pilot Study of Aprepitant Versus Ondansetron for the Treatment of Opioid Induced Nausea and Vomiting
Conditions
Interventions
aprepitant
ondansetron hydrochloride
Start Date
August 1, 2007
Primary Completion Date
January 1, 2008
Completion Date
March 1, 2008
Last Updated
April 2, 2013
NCT07388563
NCT06337318
NCT06263491
NCT06285890
NCT05529069
NCT06311227
Lead Sponsor
Vanderbilt-Ingram Cancer Center
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions